According to an article published by NBC UNIVERSAL in April 2024, experts from the U.S. Preventive Services Task Force (USPSTF) recommended that people with breasts undergo an annual mammogram starting at age 40. The rising prevalence of breast cancer across the globe is anticipated to fuel product demand. Cancer is one of the leading causes of death globally, and breast cancer is the second most common cancer worldwide. In the case of women, breast cancer tops the list of most prevalent cancers.
Rise in sedentary lifestyle, obesity, and changes in eating habits are some of the major factors contributing to breast cancer. Moreover, rising alcohol consumption is also expected to increase the risk of disease. The risk increases by around 7% to 10% per unit of alcohol consumption per day. Such an increasing prevalence of the disease is expected to boost the demand for breast ultrasound shortly.
Due to the rising demand for the prevention and treatment of this disease, key companies and research organizations are launching technologically advanced products to strengthen their foothold in the breast ultrasound market. Furthermore, the American Cancer Society's Cancer Facts & Figures 2025 estimated that more than 316,950 new invasive breast cancer cases would be diagnosed among women in the U.S. in 2025, underscoring the continued need for advanced breast imaging technologies.
In addition, the growing prevalence of dense breast tissue among women and increasing awareness regarding supplemental screening are further driving market growth. Mammography often has reduced sensitivity in women with dense breast tissue, making breast ultrasound an important complementary imaging modality for early lesion detection. According to the U.S. FDA’s breast density notification rule, effective September 2024, mammography facilities are required to inform patients about breast density, increasing awareness regarding supplemental screening options such as breast ultrasound. This regulatory development is expected to support the adoption of breast ultrasound over the forecast period.
Global Breast Ultrasound Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global breast ultrasound market report based on product, end use, and region:Product Outlook (Revenue, USD Billion, 2021 - 2033)
- Conventional Breast Ultrasound (CBUS)
- Automated Breast Ultrasound (ABUS)
End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Hospital
- Diagnostics Imaging Laboratories
- Others
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
▪ Canada
▪ Mexico
- Europe
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
- Asia Pacific
▪ China
▪ India
▪ Australia
▪ South Korea
▪ Thailand
- Latin America
▪ Argentina
- Middle East and Africa (MEA)
▪ Saudi Arabia
▪ UAE
▪ Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
This product will be delivered within 2 business days.
Table of Contents
Companies Mentioned
- GE HealthCare
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Canon Inc.
- Telemed Medical Systems Srl
- Hologic, Inc.
- FUKUDA DENSHI
- SuperSonic Imagine
- Lunit Inc.
- SamsungHealthcare.com.

